Changes in the stool and oropharyngeal microbiome in obsessive-compulsive disorder/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-22

Curated date: 2023/03/28

Curator: Kahvecirem

Revision editor(s): Kahvecirem, Claregrieve1

Subjects

Location of subjects
Spain
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Obsessive-compulsive disorder Anancastic neurosis,obsessive compulsive disorder,obsessive-compulsive disorder,OCD,Obsessive-compulsive disorder
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control (healthy group)
Group 1 name Corresponds to the case (exposed) group for case-control studies
OCD T3
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with obsessive-compulsive disorder (OCD) which is a neuropsychiatric condition characterized by intrusive and unwanted thoughts (termed obsessions) and repetitive behaviors or mental acts (termed compulsions), which are carried out to at least partially alleviate the anxiety or distress brought on by the obsessions. Timepoint 3 is following three months of pharmacological treatment and cognitive behavioral therapy (referred to as T3).
Group 0 sample size Number of subjects in the control (unexposed) group
33
Group 1 sample size Number of subjects in the case (exposed) group
31

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.0
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged
Richness Number of species
unchanged
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-22

Curated date: 2023/03/29

Curator: Kahvecirem

Revision editor(s): Claregrieve1, Kahvecirem, Merit, Atrayees

Source: Figure S4

Description: Differential microbial abundance in stool samples between controls and OCD patients at the T3 timepoint

Abundance in Group 1: increased abundance in OCD T3

NCBI Quality ControlLinks
Alistipes
Anaerostipes
Anaerotruncus
Barnesiellaceae
Bilophila
Coprobacter
Eisenbergiella
Flavonifractor
Holdemania
Hungatella
Oscillibacter
Pygmaiobacter
Rikenellaceae
Ruminiclostridium

Revision editor(s): Claregrieve1, Kahvecirem, Merit, Atrayees

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-22

Curated date: 2023/03/29

Curator: Kahvecirem

Revision editor(s): Kahvecirem, Merit, Claregrieve1

Source: Figure S4

Description: Differential microbial abundance in stool samples between controls and OCD patients at the T3 timepoint

Abundance in Group 1: decreased abundance in OCD T3

NCBI Quality ControlLinks
Catenibacterium
Coprococcus
Intestinibacter
Lachnospira sp.
Paraprevotella
Peptostreptococcaceae
Prevotellaceae
Romboutsia
Veillonellaceae

Revision editor(s): Kahvecirem, Merit, Claregrieve1